Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78
FDA recall notice · announced July 4, 2012 · Teva Pharmaceuticals
Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.
The product
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78
Reason for recall
Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Notes
Distribution: Nationwide
Lot/code information: Lot # 34000741A; Expiration date: 7/2013
Quantity: 4188 cartons (5 X 5 blisterpacks)
Status: Terminated
Products in this recall event:
- Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dos (D-1396-2012)
Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.